Mucormycosis can be a devastating and fatal disease if not treated promptly; unfortunately diagnosis can be a delayed process. Depending on the Hospitals ́ resources diagnosis can be more accurate or not. The mainstay of treatment is still surgical debridement with antifungal therapy. We present a case of a 75-year-old female, with immunosuppression and uncontrolled diabetes that presents to the...

The incidence of mucormycosis, an invasive fungal disease, is more in the developing countries, especially among immunocompromised individuals. However, this disease can also occur those without any predisposing factors. In developed undergoing haematopoetic stem cell transplantation were prone to disease. There be varied presentations mucormycosis. It could rhinocerebral, pulmonary, cutaneous,...

Figure 1. Yellow-black discoloration of upper palate. Figure 2. Paranasal sinus CT scan revealed a defect of the nasal septum and skin and subcutaneous edema.

phadenopathy. Laboratory studies revealed a hematocrit of 18.3%, platelet count 118000/mm3, and leukocyte count of 5200/mm3 with 81% lymphoblasts, 1% myelocytes, 4% neutrophils and 14% lymphocytes. The bone marrow smear showed 95% blast cells. Intravenous piperacillin and gentamicin therapy was started on an empirical basis. After 10 days without response to the antibiotic regimen, he received ...

We report a case of a 28-year-old man with acute lymphoblastic leukemia who developed rhinocerebral zygomycosis during induction chemotherapy. This life-threatening fungal infection is an infrequent cause of neutropenic fever, and is occasionally found in patients with leukemia and lymphoma, or patients with severely compromised defence mechanisms due to other diseases. It is caused by moulds b...

Background: Mucormycosis is a rare fatal infection caused by ubiquitous fungus from the order of Mucorales, which can have varying clinical presentations. Immunocompromised patients are particularly susceptible to mucormycosis and suffer consequences if not treated adequately. COVID-19 with its immunomodulatory properties has been associated wide range secondary bacterial fungal infections. We ...